BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 378849)

  • 1. Mouse protective capabilities of Escherichia coli hybrids expressing Salmonella typhi antigens.
    Diena BB; Lior H; Ryan A; Krol P; Johnson EM; Baron LS
    Infect Immun; 1979 Apr; 24(1):90-3. PubMed ID: 378849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of two Salmonella typhimurium hybrids as challenge organisms in a system for the assay of typhoid vaccines.
    Johnson EM; Diena BB; Lior H; Ryan A; Krol P; Baron LS
    Infect Immun; 1982 Oct; 38(1):201-5. PubMed ID: 6754614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of parenteral and oral typhoid vaccination in mice challenged with a Salmonella typhi-Salmonella typhimurium hybrid.
    Diena BB; Ryan A; Wallace R; Johnson EM; Baron LS; Ashton FE
    Infect Immun; 1977 Mar; 15(3):997-8. PubMed ID: 67085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assay of typhoid vaccines with Salmonella typhosa-Salmonella typhimurium hybrids.
    Diena BB; Johnson EM; Baron LS; Wallace R; Greenberg L
    Infect Immun; 1973 Jan; 7(1):5-8. PubMed ID: 4120357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ineffectiveness of Vi and chemically treated endotoxins as typhoid vaccines in mice challenged with a Salmonella typhosa-Salmonella typhimurium hybrid.
    Diena BB; Ryan A; Wallace R; Ashton FE; Johnson EM; Baron LS
    Infect Immun; 1975 Dec; 12(6):1470-1. PubMed ID: 1107227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stable expression and immunogenicity in a attenuated Salmonella typhi strain of coli surface antigen-6 of enterotoxigenic Escherichia coli].
    Teng J; Rui X; Zhang Y; Zhang Z; Su G
    Wei Sheng Wu Xue Bao; 1999 Dec; 39(6):533-8. PubMed ID: 12555559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential functional patterns of memory CD4
    Salerno-Gonçalves R; Tettelin H; Luo D; Guo Q; Ardito MT; Martin WD; De Groot AS; Sztein MB
    Vaccine; 2020 Jan; 38(2):258-270. PubMed ID: 31629569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Killing of Salmonella enterica Serovar Typhi by Antibodies Targeting Vi and Lipopolysaccharide O:9 Antigen.
    Hart PJ; O'Shaughnessy CM; Siggins MK; Bobat S; Kingsley RA; Goulding DA; Crump JA; Reyburn H; Micoli F; Dougan G; Cunningham AF; MacLennan CA
    PLoS One; 2016; 11(1):e0145945. PubMed ID: 26741681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraperitoneal immunization of recombinant HSP70 (DnaK) of Salmonella Typhi induces a predominant Th2 response and protective immunity in mice against lethal Salmonella infection.
    Paliwal PK; Bansal A; Sagi SS; Sairam M
    Vaccine; 2011 Sep; 29(38):6532-9. PubMed ID: 21767594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a novel antigen expressing system to study the Salmonella enterica serovar Typhi protein recognition by T cells.
    Salerno-Gonçalves R; Tettelin H; Lou D; Steiner S; Rezwanul T; Guo Q; Picking WD; Nene V; Sztein MB
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005912. PubMed ID: 28873442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of typhoid antigens in protection and pathogenicity for mice.
    Diena BB; Baron LS; Johnson EM; Wallace R; Ashton FE
    Infect Immun; 1974 Jun; 9(6):1102-4. PubMed ID: 4598256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and characterization of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a.
    Cryz SJ; Fürer E; Baron LS; Noon KF; Rubin FA; Kopecko DJ
    Infect Immun; 1989 Dec; 57(12):3863-8. PubMed ID: 2807550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vi Capsular Polysaccharide Produced by Recombinant
    Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
    Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Vi antigen of Salmonella typhi: molecular analysis of the viaB locus.
    Kolyva S; Waxin H; Popoff MY
    J Gen Microbiol; 1992 Feb; 138(2):297-304. PubMed ID: 1564441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909.
    Wang JY; Noriega FR; Galen JE; Barry E; Levine MM
    Infect Immun; 2000 Aug; 68(8):4647-52. PubMed ID: 10899868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assay of typhoid vaccines in mice.
    Sterne M; Trim G
    J Med Microbiol; 1974 May; 7(2):197-203. PubMed ID: 4600291
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment of typhoid vaccines by using the intraperitoneal route of challenge.
    Carter PB; Collins FM
    Infect Immun; 1977 Sep; 17(3):555-60. PubMed ID: 332627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against Salmonella typhi infection in mice after immunization with outer membrane proteins isolated from Salmonella typhi 9,12,d, Vi.
    Isibasi A; Ortiz V; Vargas M; Paniagua J; González C; Moreno J; Kumate J
    Infect Immun; 1988 Nov; 56(11):2953-9. PubMed ID: 2844676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.